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INTRODUCTION “It is the duty of the anesthesiologist to study the well being of the patient as well as
the convenience of the surgeon” - Ralph Waters The International Association for the study of pain
(IASP) defined pain as “an unpleasant sensory or emotional experience associated with actual or
potential tissue damage or described in terms of such damage”. Spinal anaesthesia was first
performed by August Bier on 16 th August 1898 when he injected 3 ml of 0.5% Cocaine intrathecally. It
is a simple technique which has many advantages over epidural anesthesia. In addition, correct
placement of the needle in the subarachnoid space is confirmed by a clearly defined end point
(appearance of...
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ABSTRACT
We conducted double blinded randomized control study in 60 patients
undergoing elective lower abdominal surgeries in spinal anaesthesia. Our aim was to
evaluate the effects of intrathecal midazolam 2mg and clonidine 30mcg as adjuvant
for hemodynamic stability and postoperative analgesia.  Patients were divided into
two groups BM and BC. BM Group received 3ml of 0.5% heavy bupivacaine, 0.4
ml of midazolam and 0.1ml of normal saline. BC Group received 3 ml of 0.5%
heavy bupivacaine, 0.2ml clonidine and 0.3ml normal saline. The total volume of the
injected solution was 3.5ml in both groups. The onset and duration of sensory and
motor blockade, pulse rate, mean arterial pressure, duration of analgesia and
average dose of postoperative analgesia were observed in both groups. In our study
the duration of analgesia was 486.17 minutes in BM group and 306.17 minutes in
BC group. The average dose of postoperative analgesia in BM group was 87.5 mg
whereas in BC group it was 132.5 mg. The MAP was significantly lower in 15
minutes and 20 minutes in BC group. We concluded in BM group the duration of
postoperative analgesia was longer and hemodynamic stability was better than BC
group.
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2INTRODUCTION
“It is the duty of the anesthesiologist to study the well being of the patient
as well as the convenience of the surgeon”
      - Ralph Waters
 The International Association for the study of pain (IASP) defined pain as
“an unpleasant sensory or emotional experience associated with actual or
potential tissue damage or described in terms of such damage”(1).
 Spinal anaesthesia was first performed by August Bier on 16th August
1898 when he injected 3 ml of 0.5% Cocaine intrathecally. It is a simple
technique which has many advantages over epidural anesthesia. In addition,
correct placement of the needle in the subarachnoid space is confirmed by a
clearly defined end point (appearance of CSF).
 Spinal anaesthesia with local anaesthetic agents is extensively used for
lower abdominal surgeries. It provides the excellent pain relief as compared to
intravenous or epidural route.
There are many advantages for spinal anesthesia over general anaesthesia
which makes it the anesthesia of choice in current surgical practice. Many
clinical studies support the fact that Postoperative morbidity and mortality may
3be reduced when neuraxial blockade is used either alone or in combination with
general anaesthesia. Since it decreases the stay, it is cost effective for both
patient and hospital. It is suitable for patients with respiratory diseases and helps
preventing intubation related problem like laryngospasm. It is also helpful in
maintaining the airway patency and reduced blood loss. Early return of gastro
intestinal function following surgery can be considered as an added advantage.
Other advantage may be reduced hypercoagulable state associated with surgery,
increased tissue blood flow due to sympathectomy, decreased splinting which
improves oxygenation, enhanced peristalsis, and reduced stress response to
surgery due to suppression of neuroendocrine system (2).
Apart from the theoretical risk of infection to the brain, difficulty in finding
the space in old age and bony abnormalities can pose a challenge to the
anesthesiologist.  The serious complication associated with spinal anaesthesia
includes bradycardia, hypotension, prolonged motor block and high spinal (3). It
is related to the sympatholytic effect of local anaesthetic agents.
If the level of the block is higher, the sympatholytic effect will be more
and leads to more serious complications. Though these effects cannot be
abolished completely, they can be considerably minimized by using either low
dose or low concentration of local anesthetics. One of the main disadvantages is
the limited duration of block achieved with local anaesthetics. To overcome this,
4various adjuvants have been tried and used successfully.
 This addition of adjuvant has further expanded the advantage of regional
anesthesia like
i) Rapid onset of action
ii) Reduces the local anesthetic requirements
iii) Reduces the risk of local anesthetic toxicity
iv) Prolongs the sensory block
v) Reduces the duration of motor block
vi) Improves the analgesic quality
vii) Improves the hemodynamic stability
viii) Inhibition of tourniquet pain
ix) Improved and prolonged duration of postoperative analgesia.
Initially opioids like morphine, fentanyl are used as spinal adjuvants. But
these have got many side effects and complications like early / late respiratory
depression, pruritus, nausea, vomiting, delayed gastric emptying and urinary
retention. There is an active search for an alternative for an ideal adjuvant which
is devoid of these side effects and complications.
In the last decades benzodiazepines, alpha 2 agonist, acetylcholine
esterase inhibitors like neostigmine and NMDA receptor antagonist like ketamine
are all used as adjuvants to local anaesthetics.
5Ketamine and Neostigmine were used as adjuvants compared with
Midazolam in Maryam shokrpur et al (4), Abdul muthalib hussain et al (5)
respectively. Both studies have shown that Midazolam group had an effective
analgesia with minimal side effects compared to the other adjuvants.
Among the neuraxial adjuvants, Midazolam and Clonidine are becoming
increasingly popular, because of their prolonged duration of analgesia, good
intraoperative comfort like anxiolysis, sedation and sparing effect on
postoperative analgesic consumption. Comparative studies with Midazolam and
Clonidine as adjuvants to intrathecal bupivacaine are very few.
In order to address these existing problems we need better pain
management which is helpful for early recovery of motor function and reduction
in requirement of postoperative analgesics.
Suchita A.Joshi et al (6), have carried out studies to compare the effect of
intrathecal midazolam and clonidine added as an adjuvant to bupivacaine in
lower abdominal surgeries. The results were promising with prolonged duration
of analgesia with lesser amount of rescue analgesics.
 This research is designed to study the efficacy of such combination in our
setup and compare the results with the previous studies done at other institutions.
6AIM OF THE STUDY
 To evaluate the efficacy of intrathecally administered adjuvants
Midazolam and Clonidine with Bupivacaine for hemodynamic stability and
postoperative pain relief in lower abdominal surgeries.
7SPINAL ANAESTHESIA
Spinal (subarachnoid / intrathecal ) anaesthesia is a form of central
neuraxial block in which a temporary interruption of nerve transmission is
achieved following injection of local anesthetic and / or adjuvant solutions into
the subarachnoid space. Spinal anaesthesia is the most frequently employed
method of regional anesthesia.
ANATOMY
The vertebral canal extends from the foramen magnum to the sacral
hiatus.It is formed by the dorsal spine, pedicles and lamina of successive
vertebrae (7 cervical, 12 thoracic, 5 lumbar and 5 sacral). The vertebrae are held
together by a series of overlapping ligaments namely the anterior and posterior
longitudinal ligaments, ligamentum flavum, interspinous ligament, supraspinous
ligament and the intervertebral discs.
The spinal cord, a direct continuation of the medulla oblongata
begins at the upper border of the atlas and terminates distally in the conus
medullaris. The distal termination, because of the differential growth rates
between the bony vertebral canal and central nervous system varies from L3 in
the infant, to the lower border of Ll or upper border of L2 in the adult.
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Surrounding the spinal cord in the bony vertebral column are three
membranes innermost the piamater ,middle one arachnoid and outer duramater.
The piamater is a highly vascular membrane that closely invests the spinal cord.
The arachnoidmater is a delicate nonvascular membrane closely attached to the
outermost duramater. Between the two innermost membranes is the subarachnoid
space. In this space are the cerebrospinal fluid, spinal nerves, blood vessels that
supply the spinal cord and the denticulate ligaments. Although the spinal cord
ends at the lower border of L1 in adults, the subarachnoid space continues to S2.
The outermost membrane in the spinal canal is the longitudinally organized
fibroelastic membrane, the duramater. This layer is the direct extension of the
cranial duramater and extends as the spinal duramater from the foramen magnum
to S2, where the filum terminale (an extension of thç piamater beginning at the
conus medullaris) blends with the periosteum of the Coccyx. There is a potential
space between the duramater and arachnoid, subdural space which contains only
small amounts of serous fluid to allow the duramater and arachnoidmater move
over each other.
Surrounding the duramater is the epidural space which extends from the
foramen magnum to the sacral hiatus. Posterior to the epidural space is the
ligamentum flavum which extends from the foramen magnum to the sacral hiatus.
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The ligamentum flavum connects the caudal edge of the vertebrae above to the
cephalad edge of the lamina below. This ligament is composed of elastic fibres
and is usually recognized by its increased resistance to the passage of the needle.
Immediately posterior to the ligamentum flavum is the interspinous ligament. It
connects the spinous processes on their horizontal surface. Extending from the
external occipital protuberance to the coccyx, posterior to these structures is the
supraspinous ligament. It connects the apices of the spinous processes. Lumbar
puncture is routinely done below the L2 vertebrae down to the L5-Si interspace
to avoid damaging the spinal cord which ends at the lower border of L1 in adults.
PHYSIOLOGY OF SUBARACHNOID BLOCK:
Cercbrospinal Fluid
The cerebrospinal fluid (CSF) is an ultrafiltrate of blood plasma with
which it is in hydrostatic and osmotic equilibrium. It is a clear, colorless fluid
found in the spinal and cranial subarachnoid space and in the ventricles of the
brain. The average volume in the adult ranges from 120-150 ml of which 35 ml is
in the ventricles, 25 ml is in the cerebral subarachnoid space and 75 ml is in the
spinal subarachnoid space. It is secreted by the choroid plexus at a rate of 0.3-0.4
mi/minute and is absorbed into the venous sinuses through the arachnoid villi.
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PHYSICAL CHARACTERISTICS OF CEREBROSPINAL FLUID (7)
pH 7.4
Specific gravity 
At body temperature
At 4 degree centigrade
1.007
1.0003
Density 1.0003 g/ml
Baricity 1.000
Pressure 8-12 mm Hg/70-80 mm H20
Cells 3-5/cu.mm
Proteins 20 mg/dl
The cerebrospinal fluid plays an important role in spinal anesthesia as a
media for dispersion of the local anesthetic drug to the spinal nerve roots. An
important factor determining the spread of drugs in the subarachnoid space is the
specific gravity of the injected solution compared with that of CSF.
MECHANISM OF SPINAL ANAESTHESIA
Injection of local anesthetic solution into the spinal CSF allows access to
sites of action both within the spinal cord and the peripheral nerve roots. The
nerve roots leaving the spinal canal are not covered by epineurium and are
readily exposed to the local anesthetic within the CSF. Therefore afferent
13
impulses entering the central nervous system via dorsal nerve roots and efferent
impulses, leaving via the ventral nerve roots are blocked during spinal anesthesia.
Local anesthetics block sodium channels and electrical conduction in spinal nerve
roots. There are also multiple potential actions of local anesthetics within the
spinal cord at different sites. Local anaesthetics can exert sodium channel block
within the dorsal and ventral horns, inhibiting generation and propagation of
electrical activity (8).
The order in which the nerve fibres are blocked are preganglionic
sympathetic B fibres followed by temperature fibres. (Cold before warmth),
fibres carrying pin prick sensation, touch, deep pressure, somatic motor sensation
and lastly fibres conveying vibration sense and proprioceptive impulses.
Sympathetic fibres are blocked two segments higher than sensory level. Sensory
fibres are blocked two segments higher than motor fibres. Recovery is roughly in
the reverse order.
Spread of Local Anaesthetics in subarachnoid space
Local anesthetic solution is diluted by CSF and therefore its original
concentration is of less amount than the actual mass of drug injected. Spread is
also determined by the baricity of the injected solution. Baricity is a ratio
comparing the density of a local anesthetic solution at a specified temperature to
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the density of CSF at the same temperature. A hypobaric solution has a baricity
less than 1.0000 or specific gravity less than 1 .0069(the mean value of specific
gravity). A hyperbaric solution has a baricity greater than 1.0000 or specific
gravity more than 1.0069. Hypobaric and Hyperbaric solutions are prepared from
isobaric solutions by the addition of various amounts of sterile distilled water and
dextrose respectively. Isobaric solutions do not move under the influence of
gravity in the CSF. Hyperbaric solutions, being heavier than CSF, settle to the
most dependent aspect of the subarachnoid space, which is determined by the
position of the patient. In supine patient, hyperbaric solutions gravitate to the
thoracic kyphosis. Hypobaric solution floats up to the nerves innervating the
surgical site. The major factors affecting height of the block are the baricity of
the local anesthetic solution and the dosage of drug injected.
Fate of Local Anaesthetics in Subarachnoid Space:
Following injection of local anaesthetic solution into subarachnoid
space, its concentration falls rapidly. The initial steep fall is due to mixing with
CSF and subsequent absorption into nerve roots and spinal cord, The
progress of local anesthetic solution following subarachnoid injection is primarily
by vascular absorption with no hydrolysis or degradation taking place in the CSF.
Depending on the type of the drug used, it is metabolized in plasma by
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pseudocholinesterase or in the liver. As duration of anaesthesia is in the part, a
result of the rate of absorption from the subarachnoid space, the addition of a
vasoconstrictor to the local anaestheric solution will retard absorption of the drug
and thus increase the duration of anesthesia.
FACTORS INFLUENCING BLOCK HEIGHT
a - Site of injection
b - Angulation of needle
c - Characteristic of local anaesthetic
i) Density of local anaesthetic
ii) Specific gravity
iii) Baricity
d - Dose of local anaesthetic
e - Position of the patient during and after injection
f - Anatomic configuration of spinal column.
g - Patient height (at extremes)
h - Volume of cerebrospinal fluid
i - Reduced cerebrospinal fluid with increased intra abdominal
   Pressure (eg. Pregnancy)
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INDICATIONS FOR SUBARACHNOID BLOCK:
Spinal anesthesia can be administered whenever a surgical procedure can
be done with a sensory level of anesthesia that does not produce adverse patient
outcome which includes
• Lower abdominal surgeries
• Lower limb surgeries
• Urological procedures
• Obstetric procedures
• Gynecological surgeries
• Perineal and rectal surgeries
Contraindications for subarachnoid block
Absolute contraindication
· Patient refusal
· Local sepsis
Relative contraindication
· Uncorrected coagulopathy
· Uncontrolled blood loss / shock
· Fixed cardiac output states
· Documented allergy to local anesthetics
· Raised intracranial pressure
17
· Neurological disease
· Major spine deformities / previous surgery on the spine
· Severe cardiac disease
18
Complications of subarachnoid block
Immediate
· Hypotension
· Bradycardia
· Toxicity due to intra vascular injection
· Allergic reaction to local anesthetic
· Hypoventilation (in patients with higher thoracic levels )
· Postdural puncture headache
· Retention of urine
· Back ache
· Meningitis
· Transient lesions of cauda equinae
· Sixth nerve palsy
· Anterior spinal artery syndrome
· Horner’s syndrome
19
CIRCULATORY CHANGES
a) Neural Blockade
 Local anaesthetic solutions injected into the subarachnoid space produce a
conduction  block of small diameter unmyelinated ( sympathetic ) fibres before
interrupting conduction in larger unmyelinated (sensory  and motor ) fibres. As a
result level of automatic blockade extends above the level of the sensory
blockade by two to six segments. This phenomenon is termed differential
blockade (9).
 Similarly fibres conveying sensation are more easily blocked than larger
motor fibres so that sensory blockade will extend above the level of the motor
blockade.
b) Cardiovascular system
 Hypotension is directly proportional to the degree of sympathetic blockade
produced. Sympathetic blockade results in dilation of arteries and venous
capacitance vessels leading to decreased systemic vascular resistance and
decreased venous return.
 If the block is below T4, increased baroreceptor activity produces an
increase in activity to cardiac sympathetic fibres and vasoconstriction of the
upper extremities.  Blockade above T4 interrupts cardiac sympathetic fibres
20
leading to bradycardia, decreased cardiac output and a further decrease in blood
pressure and fall in Right atrial filling which decreases outflow from intrinsic
chronotropic stretch receptors located in the right atrium and great veins(9).
c) Respiratory system
1. Usually not clinically significant in healthy patient because the
diaphragm is innervated by phrenic nerve (C3-C5)
2. Respiratory rate and tidal volumes remain unchanged, though a high
thoracic level block can result in decreased expiratory reserve
volume from deafferentation of the abdominal wall and intercostal
muscles (10).
Caution is advised in performing neuraxial blocks in patients with limited
respiratory reserve, who may be dependent on these muscles for active
respiration and clearing of secretions.  Respiratory arrest associated with high
spinal is attributed to hypo perfusion of the medullary respiratory neurons, rather
than phrenic nerve block.
e) Hepatic and Renal Effects
 The hepatic blood flow decreases and is directly proportional to the
decrease in blood pressure (11). There may be normal hepatic oxygen extraction.
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 Renal blood flow is maintained by autoregulation and does not decrease till
mean arterial pressure go below 50mmHg.
f) Gastrointestinal and genito urinary system
 Nausea and vomiting may be associated with neuraxial block related to
gastrointestinal hyper peristalsis caused by unopposed parasympathetic activity.
Handling of the viscera causes discomfort and bradycardia since vagus is not
blocked.
 Sacral blockade (S2 to S4) results in an atonic bladder that can retain large
volumes of urine Blockade of sympathetic afferent and efferent innervation of the
spincter and detrusor muscle produces urinary retention. Penis is often engorged.
g) Metabolic and hormonal effect
 Spinal anaesthesia blocks hormonal and metabolic responses to
nociceptive stimuli arising from the operative site. It minimizes the rise in blood
sugar, cortisol, catecholamines, renin and aldosterone release associated with
stress. Vagal afferent fibres from upper abdominal viscera are not blocked and
can stimulate release of hypothalamic and pituitary hormones such as antidiuretic
hormone and adrenocorticotrophic hormone.
h) Thermo Regulation
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Hypothermia results from redistribution of central heat to the periphery
secondary to vasodilatation. Thermoregulation is impaired given the loss of
vascoconstriction to preserve the heat below the level of sympathectomy.
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PHARMACOLOGY OF DRUGS
a) Bupivacaine
 Bupivacaine is an amide linked local anaesthetic. It is a hydrochloride salt
of d(1)-1-butyl 2’6’ pipecoloxylidide and is presented as a racemic mixture.
· It was synthesized in Sweden by Ekenstem and his colleagues in 1957.
· First reports of its use were published in 1963 by Telivuo.
· It is derived from Mepivacaine which has a methyl group on the piperidine
nitrogen atom of the molecule. Addition of a butyl group to the piperidine
nitrogen of the mepivacaine results in bupivacaine which is 35 times more
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lipid soluble and has a potency and duration of action 3 to 4 times that of
mepivacaine.
Pka is 8.1
MW - 288
Protein binding  - 95%
Volume of Distribution – 73 Litres
Lipid solubility – 28
Clearance - 0.47 l/min
Elimination half life - 210mts
Toxic plasma concentration - > 3 mg/ml
Availability
 Ampoules - 0.5% Bupivacaine hydrochloride 4cc
- 0.5% Bupivacaine hydrochloride with dextrose (heavy)
4cc
 Vials  - 0.25% and 0.5% Bupivacaine hydrochloride 30cc
 Dosage - Maximum dosage 3mg/kg body weight.
Uses
· Spinal anaesthesia
· Epidural anaesthesia
· Caudal anaesthesia
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· Continuous epidural anaesthesia
· Peripheral nerve block
Onset time and duration of action
Site of action Onset (minutes) Duration (minutes)
Intrathecal 5 180-240
Epidural 15-20 165-225
Brachial plexus 20-30 360-720
Pharmacokinetics
It is a weak base that has pka value above physiological pH. At  pH 7.4
only 17% exists in nonionised form.
 Once injected intrathecally, it gets absorbed by the nerve rootlets and
results in the desired effect. It is rapidly absorbed from the site of injection, but
the rate of absorption depends on the vascularity at the site and presence of
vasoconstrictors.
 Absorption of a local anaesthetic from its site of injection into the systemic
circulation is influenced by site of injection dosage and use of epinephrine. The
plasma concentration is determined by rate of tissue distribution and rate of
clearance of the drug. High lipid solubility of bupivacaine makes it easy for nerve
and vascular tissue penetration (12).
 Lung is capable of extracting bupivacaine from circulation, which will limit
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concentration of drug that reaches systemic circulation. This first pass pulmonary
extraction is dose dependent suggesting that the uptake process becomes
saturated rapidly.
Placental transfer
 There may be clinically significant transplacental transfer between mother
and fetus. Plasma protein binding influences the rate and degree of diffusion of
local anaesthetics across the placenta.
Distribution
Rapid distribution phase: (α)
 In this phase the drug is distributed to highly vascular region.
 t ½  of α  - being 2.7 minutes.   
Slow disappearance phase: (β)
In this phase the drug distributes to slowly equilibrating tissues
 t ½  of β – being 28mts.
Biotransformation and excretion phase: (δ )
t ½  of δ is 3.5hours, clearance is 0.47 litre/minute.
Biotransformation
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 Possible pathways of metabolism of bupivacaine include aromatic
hydroxylation N-dealkylation, amide hydrolysis and conjugation. Only the
N-dealkylated metabolite, N-desbutyl bupivacaine has been measured in blood
(or) urine after epidural (or) spinal anaesthesia. Alpha1 acid glycoprotein is the
most important plasma protein binding site of bupivacaine and its concentration
is increased by many clinical situations including postoperative trauma.
Excretion:
 The poor water solubility of local anaesthetics usually limits renal
excretion of unchanged drug to <5%
Mode of Action
a) Site of action
i) The spinal nerve rootlet fine nerve filaments having a large surface area
are exposed to the local anaesthetics.
ii) Posterior and lateral aspects of the spinal cord itself.
b) Sodium Channel blockade
 Local anaesthetics prevent transmission of nerve impulses by inhibiting
passage of sodium ions though ion-selective sodium channels in nerve
membranes. Failure of sodium ion channel permeability to increase slows the rate
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of depolarization such that threshold potential is not reached and thus an action
potential is not propagated. Local anaesthetics do not alter the resting
transmembrane potential or threshold potential.
Pharmacodynamics
 It has got a longer duration of action but a slower onset.
Cardiovascular system
 It reduces cardiac output by reducing the sympathetic tone, by slowing the
heart rate and by reducing the venous return, it produces a fall in arterial blood
pressure but it is relatively slow and is seldom very profound.
 It produces a fall in central venous pressure. It causes an increase in lower
limb blood flow. It causes a reduction in incidence of deep vein thrombosis.
Respiratory System
 Spinal blockade seldom, if ever causes respiratory problem.
Gastro intestinal tract
 There is an increase in gastro intestinal motility and emptying of the gastric
contents are better. 
Toxicity
 Toxicity is related to plasma level of unbound drug and more likely due to
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an inadvertent intravenous injection. Systemic toxicity reactions primarily involve
central nervous system and cardio vascular system. The blood level required to
produce central nervous system toxicity is less than that required to produce
circulatory collapse.
Central Nervous System Toxicity
 Initial symptom includes feeling of light headedness and dizziness,
followed by visual and auditory disturbances. Objective signs are excitatory and
include shivering, muscle twitching and tremor. Ultimately generalized tonic,
clonic seizures occurs.
Cardiovascular System Toxicity
 Bupivacaine is more cardiotoxic than equieffective doses of lignocaine.
This is manifested by severe ventricular arrhythmias and myocardial depression.
Bupivacaine blocks cardiac Na+ channels rapidly during systole and dissociates
more slowly during diastole, so that a significant fraction of Na+ channels remain
blocked at the end of the diastole. Thus the block by bupivacaine is cumulative
and substantially greater.
 The rate of depolarization in fast conducting tissue of  Purkinje fibres and
ventricular muscle is decreased. The rate of recovery of bupivacaine induced
block is slower than that of lignocaine. Extremely high concentration of the drug
causes sinus bradycardia and cardiac arrest.
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PHARMACOLOGY OF MIDAZOLAM
Benzodiazepines were introduced in early 1960s. Diazepam was the most
popular drug in this group for the initial 2 decades. It water insoluble, has a
prolonged effect and painful during injection. Midazolam was synthesized in
1976 by Tryer and walser and is midazolam is a water soluble
imidobenzodiazepine. The unique chemical structure of midazolam confers a
number of physicochemical properties that distinguish it from other
benzodiazepines.
CHEMISTRY
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Benzodiazepines are so called because they consist of a benzene ring
fused with a seven member diazepine ring. Various modifications in the structure
of the ring systems have yielded compounds with similar activities.
 Midazolam has a fused imidazole that is different from classic
benzodiazepines. The imidazole ring accounts for the stability of an aqueous
solution and rapid metabolism. The ring exhibits a pH dependent ring opening
phenomenon. The ring opens at pH less than 4 making the drug soluble in
aqueous solution. Once midazolam enters the body, the pH changes to 7.4 and
drug assumes closed ring structure and becomes highly lipid soluble.
AVAILABILITY
Available as one ml ampoule containing 5mg of preservative free
midazolam
· 1 vial containing 10mg of midazolam (preservative added)
· Nasal spray
· Oral preparation
PHARMACOKINETICS
 After oral administration, midazolam is rapidly absorbed from the
gastrointestinal tract. Peak concentrations are achieved within one hour of
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ingestion. Because of extensive first pass metabolism only 40-50 percent of oral
dose reaches systemic circulation. Hence Oral dose should be twice higher than
intravenous dose to achieve comparable clinical effects.
 Peak plasma concentrations are seen within an hour of ingestion. When
given intramuscularly, the absorption is more predictable than diazepam. Being
highly fat soluble it crosses blood brain barrier more easily than diazepam, to
gain access to the receptors. It has a more rapid onset (within 30-60 seconds) of
action. The half life of equilibrium between plasma concentration and EEG effect
is 2 to 3 minutes and is not affected by age.
 After intravenous administration of midazolam to healthy adults the
disappearance of midazolam from the plasma proceeds in two distinct phases.
The initial phase of rapid disappearance is due to distribution of the drug while
the final and slower phase of disappearance is attributable mainly to
biotransformation. The more rapid redistribution accounts for the shorter
duration of action.
  Molecular weight   - 362
  PKa    - 6.2 (20°)
  Elimination half life - 1.7-2.6 hr
Clearance    - 6.4 -11 ml/ kg/min
Volume of Distribution - 1.1-1.7 l / kg
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Protein binding  - 96 – 98%
METABOLISM
Midazolam is metabolized mainly by hepatic microsomal oxidative
mechanism, by a process of hydroxylation. The fused imidazole ring is oxidized
very rapidly to both 1 and 4 hydroxy midazolam. Both these products are
conjugated to glucuronides and are excreted in the urine. The metabolites have
less than 1% activity of the parent drug.
MECHANISM AND SITE OF ACTION
1. Gamma – aminobutyric acid  (GABA), the principal inhibitory
neurotransmitter in CNS. Benzodiazepines do not activate the
GABAA receptor but rather enhance the affinity of the receptors for
GABA. As a result, there is enhanced opening of chloride gating
channels, resulting in increased chloride conductance producing
hyper polarization of the post synaptic cell membrane and rendering
post synaptic neurons more resistant to excitation. This resistance to
the excitation is presumed to be the mechanism.
2. Sedation, anterograde amnesia and anticonvulsant properties are
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mediated via a1 GABAA receptors. Anxiolysis and Muscle
relaxation are mediated by the a2 GABAA receptor (13).
3. Benzodiazepine receptors are found in highest densities in the
olfactory bulb, cerebral cotex, cerebellum, hippocampus, substantia
nigra and inferior calculus but in lower densities in the striatum,
lower brainstem and spinal cord.
4. Benzodiazepine receptors in the Spinal cord can play an important
role in analgesia.
5. Intrathecal midazolam reduces excitatory GABA – mediated
transmission in interneurons, leading to a decrease in the excitability
of spinal dorsal horn neurons (14). 
6. Intrathecal midazolam added to bupivacaine spinal increases
analgesia and shortens the time to return of motor function (15).
PHARMACODYNAMICS
CENTRAL NERVOUS SYSTEM
 Midazolam has anxiolytic, hypnotic, anticonvulsant, muscle relaxant and
anterograde amnestic properties. It decreases the cerebral metabolic oxygen
requirements (CMRO2) and cerebral blood flow. Midazolam induces dose
dependent changes in regional cerebral perfusion in the parts of the brain that
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subserve arousal, attention and memory.  Cerebral vasomotor responsiveness to
carbondioxide is preserved during midazolam anaesthesia.  Cerebral perfusion
pressure decrease as the systemic pressure falls more than the intracranial
pressure. Given in doses of 0.25mg/kg it does not alter intracranial tension and
therefore it can be used for neurosurgical procedures.  Emergence from induction
is more rapid than diazepam, but not so, when compared with thiopentone.
Midazolam decreases the anaesthetic requirement of inhalational agents.
 When Midazolam is compared with propofol for sedation, the two are
generally similar except that emergence (or) wakeup is more rapid with propofol.
Midazolam causes better amnesia and a smoother hemodynamics when
compared with Thiopentone.
 Arousal time after repeated bolus (or) continuous infusion is less with
midazolam than diazepam and lorazepam because of the shorter contex- sensitive
half time and greater clearance of midazolam. Midazolam can increase the
seizure initiation threshold to local anaesthetics. Midazolam can cause dose
related protective effect against cerebral hypoxia (16). The protection afforded
by midazolam is superior to that of diazepam but less than that of phenobarbital.
CARDIOVASCULAR SYSTEM
Benzodiazepines maintain relatively stable hemodynamics. It involves the
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preservation of homeostatic reflex mechanism (17) but there is an evidence that
baroreflex is impaired by midazolam and diazepam.
Midazolam decreases the myocardial contractility and systemic vascular
resistance and causes vasodilatation, thus causing fall in arterial pressure.  The
fall in blood pressure is similar to that caused by hypnotic doses of thiopentone,
greater than that caused by equipotent doses of diazepam and less than that
caused by propofol (18). It increases the heart rate.  Midazolam does not abolish
the stress response to intubation (19), but the combination of benzodiazepines
with opiates produce greater decrease in systemic blood pressure due to
reduction in the sympathetic tone (20) and decreased catecholamines.
Midazolam does not alter coronary vascular resistance and does not cause
coronary steal phenomenon.
RESPIRATORY SYSTEM
Midazolam causes dose dependent depression of ventilation. Peak
decrease in minute ventilation after midazolam (0.15 mg/kg) is identical to
diazepam 3 mg/kg IV (22). The slopes of the ventilatory response curves to
carbondioxide are flatter than normal, but not shifted to right as with opioids.
The peak onset of ventilatroy depression with midazolam (0.13 to 0.2 mg /kg ) is
rapid (About 3minutes) and significant depression remains for about 60-120 min
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(23).
Apnoea produced by midazolam is dose related and is more common in
patients premedicated with opioids, in chronic obstructive pulmonary disease
patients and following faster injection of the drug.  The respiratory depression is
reversed by flumazenil but not by naloxone. It also depresses the swallowing
reflex and decrease upper airway activity.
INTRATHECAL MIDAZOLAM
  It is an agonist at the benzodiazepine binding site on a subunit of the
pentameric GABAA receptor.  This receptor is a chloride inophore that, when
activated typically stabilizes the transmembrane potential at or near the resting
potential.  In neurons, this typically serves to decrease the excitability. In
primary afferent terminals, a modest depolarization is observed that serves
paradoxically, to reduce the transmitter release, a form of presynaptic inhibition.
Consistent with these effects and benzodiazepine subunit expression in dorsal
root ganglia and on spinal neurons, benzodiazepine tends to suppress afferent
evoked excitation in the substantia galatinosa and motor horn.
DRUG INTERACTIONS
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 Erythromycin, clarithromycin and fluconazole increase the effect of
midazolam due to inhibition of cytochrome P450 III A enzyme. H2 receptor
antagonist also inhibit cytochrome P450 III A enzyme.
Asprin and probenecid increase the effect by competing for protein
binding site. Phenytoin, rifampicin and xanthines decrease  the efficacy of
midazolam due to increased metabolism by inducing cytochrome P450.
Old age, liver disease and renal disease decrease and smoking and
habitual alcohol consumption increase the clearance of midazolam.
USES OF MIDAZOLAM   DOSAGE    ROUTE
1. Induction of Anaesthesia   0.15.0.40mg/kg  iv
2. Maintenance Titration   0.25-1 mg/kg/min   iv
3. Premedication    0.07 - 0.10mg/kg   im
0.25 - 0.5mg/kg   Oral
4. Intravenus sedation 0.05 -0.15 mg/kg   iv
Adverse effects:
Depending on its dose, midazolam can cause any stage of a cardiovascular
and respiratory depression. High i.v. doses have caused cardiac and respiratory
arrest with lethal consequences. Usual doses normally cause a minor decrease of
the blood pressure and oxygen saturation. The amnesia desired can last much
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longer than the intervention, sometimes for hours (semi consciousness). In
addition to a multitude of central nervous symptoms (vertigo. dizziness,
headaches, rarely hallucinations. etc.), midazolam can also cause visual
disturbances and nausea. Repeated administration (e.g. as a sleeping aid) leads to
tolerance and dependence within weeks: withdrawal syndrome often occurs if the
drug is discontinued abruptly.
Toxicity:
Signs of overdose include sedation, somnolence, confusion, impaired
coordination, diminished reflexes, coma, and deleterious effects on vital signs.
PHARMACOLOGY OF CLONIDINE
INTRODUCTION
Clonidine hydrochloride is a centrally acting selective partial α2 agonist
(220:1) that was initially introduced as a nasal decongestant in early 1960s during
its use its anti- hypertensive property was found out.
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Clonidine hydrochloride is an imidazoline compound. The chemical name
is 2-(2, 6- dichlorophenylamino)-2-imidazoline hydrochloride.
The molecular weight is 266.56. Clonidine is an odourless, bitter, white
crystalline substance. It is soluble in alcohol and water.
AVAILABILITY
 Oral 0.1 mg, 0.2 mg, 0.3 mg tablet.
Intravenous 1 ml ampoule containing 150 mcg of clonidine as preservative
free solution.
 Transdermal patches 0.1 mg, 0.2 mg, 0.3 mg / 24 hrs.
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MECHANISM OF ACTION
Clonidine is a centrally acting selective partial α2 adrenergic agonist with a
selectivity ratio of 220: 1 in favor of α2 receptors.  There are three subtypes of
α2 receptors α2A, α2B and α2C. α2A receptors mediate  sedation, analgesia &
sympatholysis. α2B receptors mediate vasoconstriction and anti- shivering. The
startle response may reflect the activation of α2C receptors.   It stimulates the
inhibitory α2 adrenoreceptors to reduce the central neural transmission in the
spinal neurons.  Inhibition of substance- P release is believed to be involved in
the analgesic effect.
The α2 adrenoreceptors are located on the afferent terminals of both
peripheral and spinal neurons in the superficial laminae of the spinal cord and
within several brain stem nuclei implicated in analgesia (24).  The superficial
laminae contain three groups of neurons: tonic, adapting, singlespike firing, all of
which receive their primary sensory input from Aδ and C fibres. Studies in rat
models show that clonidine inhibits voltage gated Na+ and K+ channels and
suppresses the generation of action potentials in spinal dorsal horn neurons,
contributing to analgesic effect.
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Another contribution to analgesic effect may be through the release of
acetylcholine in the neuraxial region. This enhances sensory and motor block of
C and A fibres by local anaesthetics and by increasing potassium conductance.
Sedation is produced by its action on locus coeruleus.
Clonidine affects the blood pressure in a complex fashion after neuraxial
or systemic administration because of opposing action at multiple sites.  In the
nucleus tractus solitarius and locus coeruleus of the brain stem, activation of
post- synaptic α2 adrenoreceptors reduces sympathetic drive (25). It also
activates noradrenergic imidazoline preferring binding sites in the lateral reticular
nucleus producing hypotension and anti-arrythmogenic action. In the periphery it
acts on presynaptic α2 adrenoreceptors at sympathetic terminals reduces the
release of norepinephrine causing vasorelaxation and reduced chronotropic drive
(26). The brainstem and the peripheral effects of α2 adrenoreceptor stimulation
are counterbalanced by the direct peripheral vasoconstriction through its action
on α21 adrenoreceptors from the circulating concentrations of clonidine.
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PHARMACOKINETICS
 Clonidine is rapidly absorbed after oral administration and reaches peak
plasma concentration within 60 to 90 minutes. The elimination half life of
clonidine is between 9 and 12 hours with approximately 50% metabolised in the
liver whereas rest is excreted unchanged in urine. The transdermal route requires
about 48 hrs to produce therapeutic plasma concentrations.
Clonidine is highly lipid soluble and readily distributes into extra- vascular
sites including the central nervous system.
Distribution t ½   :    11+/- 9 minutes.
Elimination t1/2   :   9+/- 2 hour
Volume of distribution: 2.1+/- 0.4 L/kg
Plasma protein binding: 20-40 % in vitro.
Excretion  : 70% of the dose, mainly in the form of unchanged
     parent drug (40-60%) in urine.
PHARMACODYNAMICS
The analgesic effect of clonidine is more potent after neuraxial
administration indicating a spinal site of action, favors neuraxial administration,
though it is possible to achieve analgesia from systemic administration as well.
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CARDIOVASCULAR SYSTEM
The decrease in systolic blood pressure product by clonidine is more
potent than decrease is diastolic blood pressure.
 The ability of clonidine to decrease systemic blood pressure without
paralysis of compensatory homeostatic reflexes is highly desirable.
RESPIRATION 
a2 agonists have minimal depressant effects on ventilation and do not
potentiate ventilatory depressant effects of opioids.
SEDATION
Clonidine produces a dose dependent sedation at the dose of 50 mcg or
more in less than 20 minutes regardless of the route of administration.
PERIPHERAL NERVES
It produces a minor degree of blockade at high concentrations with some
preference for C fibres in the peripheral nerves and this effect in part enhance the
peripheral nerve block when added to local anaesthetics, probably because the
α2 adrenoreceptors are lacking on the axons of peripheral nerves.
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Clonidine prevents opioid induced skeletal muscle rigidity and produces
skeletal muscle flaccidity.α2 agonists have no effect on the responses evoked by
neuromuscular blocking drugs.
ADVERSE EFFECTS
1. Drowsiness, Dryness of mouth, Nasal mucosa and eyes. Weakness,
fatigue, headache and withdrawal syndrome.
2. Cardiovascular: Bradycardia, Hypotension, syncope, congestive heart
failure, ECG abnormalities like sinus node arrest, junctional bradycardia,
high degree AV block and arrhythmias are reported rarely. 
3. Central nervous system: nervousness, agitation, mental depression,
insomnia, vivid dreams or nightmares, anxiety, visual and auditory
hallucinations have been reported rarely.
4. Skinrash: angioneurotic edema, pruritus, utricaria and alopecia rarely.
5. Gastro intestinal tract: nausea and vomiting, anorexia.
6. Genitourinary:  decreased sexual activity, impotence, loss of libido.
7. Hematologic: thrombocytopenia rarely.
8. Metabolic: weight gain and gynaecomastia
Precautions
1. In patients with renal insufficiency, lower dose is needed.
2. Rebound hypertension can occur after abrupt discontinuation of clonidine
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therapy (1.2 mg / day) as early as 8 hours and as late as 36 hours after the
last dose (27). Rebound hypertension can usually be controlled by
reinstituting clonidine therapy or by administering a vasodilating drugs
such as hydralazine or sodium nitroprusside.
3. Use with caution in patients with cerebrovascular or coronary
insufficiency.
CONTRAINDICATIONS
1. Known hypersensitivity to clonidine or components of the product.
2. In patients with bradyarrhythmia or AV block.
3. Patients with severe cardiovascular disease
4. Patients with cardiovascular/ hemodynamic instability.
INTERACTIONS
1. Clonidine may potentiate the CNS depressive effect of alcohol,
barbiturates or other sedative drugs.
2. Narcotics may potentiate the hypotensive effects of clonidine.
3. Tricyclic anti depressants may antagonize the hypotensive effects of
clonidine.
4. Concomitant administration of drugs with a negative chronotropic/
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dromotropic effect (beta blockers, digoxin) can cause or potentiate
bradycardiac rhythm disturbances.
5. Beta blockers may potentiate the hypertensive response seen with
clonidine withdrawal.
ANAESTHETIC USES
1. Premedication:  Clonidine acting on locus ceruleus produces sedation.
Also got an anesthesia- sparing effect.
2. Control of hemodynamics: It prevents hypertension and tachycardia
during laryngoscopy and intubation as well as during surgical stimulation
decreased incidence of myocardial ischemia in cardiac and vascular
surgeries.
3. Epidural: It acts as a sole agent or in combination with opioids or local
anaesthetics to provide excellent analgesia.
4. In labour analgesia.
5. Spinal: with local anaesthetics clonidine improve the quality and duration
of the block, minimize the tourniquet pain during lower limb surgery, and
prevents shivering.
6. Caudal:  with local anaesthetics increases the duration of anaesthesia and
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analgesia 2 or 3 times without hemodynamic side effects.
7. Peripheral nerve blocks:  prolongs the duration of anaesthesia and
analgesia with local anaesthetics in a dose of 75- 150 mcg.
8. Bier’s block: 150 mcg enhance the tolerance of tourniquet.
9. Intra articular analgesia.
DOSAGE GUIDELINES
 Intrathecal  - 15 mcg to 30 mcg
 Epidural  - 1 mcg / kg (or) 50 mcg - 30 mcg / hr ( for infusion)
Intravenous - 50-75 mcg or 1 mcg /kg 15 minutes prior to induction
for intubation response attenuation.
OVERDOSAGE AND TREATMENT
There is no specific antidote for clonidine over dosage. Supportive
measures like atropine, ephedrine, i.v fluids is enough.  For hypertensive crisis i.v
furosemide, diazoxide, phentolamine can be used. Yohimbine partially reverses
the analgesia and sedation but not the BP and heart rate changes produced by the
epidural clonidine.
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Naloxone may be a useful adjunct for the management of clonidine
induced respiratory depression, hypotension and or coma. Blood pressure should
be monitored after injecting naloxone as it may produce paradoxical
hypertension.
REVIEW OF LITERATURE
C.S.Goodchild and J.Nobel et al (28), conducted a pilot study on effects
of intrathecal midazolam on sympathetic reflexes in man. Nine patients received
intrathecal midazolam, blood pressure, central venous pressure, E.C.G were
monitored continuously. Sensation, motor power and valsalva manouer were also
tested. It is concluded intrathecal midazolam blocks somatic nociceptive afferent
pathways. Visceral nociceptive afferent pathways are not affected.
     BR.J.CLIN.PHARMAC (1987) 23;279-285
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C.S.Goodchild et al (29), has published about intrathecal midazolam in
rats. In this study antinociceptive effect of intrathecal midazolam involves
release of endogenous neurotransmitters acting at the spinal cord delta opioid
receptors.
 These effects were demonstrated by measuring electrical current threshold
for avoidance behavior in rats. The results of the study implied that, intrathecal
midazolam combines with GABA ‘A’ receptors in the spinal cord and releases
endogenous opioid that acted at Kappa or delta opioid receptor but not on µ
opioid receptors.
Kim MH et al (30) in 2001, in a double-blinded study conducted the
postoperative analgesic effects of intrathecal midazolam with bupivacaine
undergoing haemorrhoidectomy surgeries, Forty-five patients were divided into
three groups: the control group received 1ml of 0.5% heavy bupivacaine plus 0.2
ml of 0.9% saline intrathecally, group BMI received 1 ml of 0.5% bupivacaine
plus 0.2ml of 0.5% preservative-free midazolam and group BM2 received 1ml of
0.5% bupivacaine plus 0.4 ml of 0.5% midazolam. In this study addition of 0.2ml
(or) 0.4ml intrathecal midazolam prolong the postoperative analgesic effect by
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6.03 hours and 8.37 hrs respectively. All patients required analgesic during 24
hours after surgery. 
Adam P.Tucker et al (31), conducted cohort study on intrathecal
midazolam. This study focused on neurotoxicity with Intrathecal midazolam.
Eleven hundred patients were followed postoperatively up to one month for the
symptoms suggestive neurotoxicity. Intrathecal midazolam up to 2 mg. did not
increase the neurologic symptoms.
     ANAESH ANALG 2004; 98; 1512-20
Dr.Nithi agarwal et al (32) conducted double blind study among 53 adult
patients on efficacy of intrathecal bupivacaine with midazolam for Postoperative
analgesia. Patients were randomly divided into two groups. Group B received 3
ml of heavy bupivacaine with 0.2 ml of 0.9% saline. BM group received 3 ml of
heavy bupivacaine with 0.2 ml of preservative free 1 mg midazolam intrathecally.
 The time for regression of sensory block in group B was 164 minutes where as
in group BM 158.6 minutes. Time to first rescue analgesic was 4 hrs in group B
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and 17 hrs in group BM. In conclusion, the duration of Postoperative analgesia
was longer in Intrathecal midazolam combination without affecting the duration
of dermatomal sensory level. There were no side effects such as nausea,
vomiting, urinary retention, hypotension, bradycardia and itching in their study.
     INDIAN J.ANAESTH 2005; 49;1;37-39
Prakash et al  (33) conducted study regarding analgesic efficacy of 1 mg
and 2 mg of intrathecal midazolam with bupivacaine in 60 patients undergoing
cesarean section. Patients were divided into three groups randomly. Group B
received 2 ml of hyperbaric bupivacaine 0.05. % . Group BM1 received 2 ml of
bupivacaine and 1 mg midazolam, and group BM2 received 2 ml of bupivacaine
with 2 ml midazolam.  The mean duration of Postoperative analgesia are 4.3 hrs
and 6.1 hrs in 1 mg and 2 mg midazolam groups respectively. The supplementary
analgesic dose of diclofenac was 93 mg in BM2 group and 148 in BM1 group.
They have concluded that the 2 mg of midazolam adjuvant causes prolongation
of post operative analgesia.
   REG ANAESH PAIN MED 2006 MAY-JUNE 31 220-226
Hema saxena M.D. et al (34), conducted study on intrathecal clonidine
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regarding onset and duration of block with hemodynamic stability. Among eighty
patients who underwent lower abdominal surgeries were divided randomly into 4
groups. Control group (I) received 13.5 mg of 0.5% bupivacaine. Group II ,
Group III, Group IV received 15 mcg , 30 mcg and 37.5 mcg of clonidine
respectively along with 13.5 mg of bupivacaine. In their study, the duration of
analgesia in patient who received 30 mcg of clonidine was 264 minutes, motor
blockade was 220 minutes and the onset of sensory block was 0.098 minutes.
With the addition of clonidine, they observed the onset time, duration of block
improved in a dose dependant manner.
 In group IV (who received 37.5 mcg of clonidine) 30% of the patients had
fall in pulse rate and blood pressure and 90% of the patients were sedated. The
hemodynamic stability was better maintained in group II and group III than group
IV. There was no significant difference between group III and group IV
regarding the time of onset of sensory and motor blockade. In conclusion, their
study has demonstrated 30 mcg of clonidine provides maximum benefits and
minimum side effects.
INTERNET JOURNAL OF ANAESTHESIOLOGY 2010.VOL.23.NO.1
Shadhangi B K et al (35), at AIIMS, in 2011 in a prospective double
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blind study evaluated postoperative analgesic efficacy of Intrathecal midazolam
2 mg as an adjuvant to Bupivacaine for spinal anesthesia in 100 patients
scheduled for elective lower abdominal, lower limb and gynecological
procedures. Patients were allocated in two groups. Group B received 3 ml of
0.5% heavy Bupivacaine with 0.4 ml normal saline and Group BM received 3 ml
of 0.5% Bupivacaine and 0.4 ml (2 mg) of midazolam. The following parameters
are recorded and comparable. Onset and duration of sensory/motor block, time to
first postoperative analgesia and adverse effects.
Onset of sensory block was 4.8 minutes in Group B and Group BM was
4.6 minutes, Onset of motor block was 5.9 minutes in Group B and 6 minutes in
Group BM. Duration of sensory block was 90.8 minutes in Group B and 115.8
minutes in Group BM, Duration of motor block was 151.8 minutes in Group B
and 151.3 minutes in Group BM. Duration of analgesia was 121.3±5.4 minutes in
Group B and 221.1±15.6 in Group BM.
Respiratory rate and O2 saturation did not differ between B and BM
groups. They concluded that intrathecal midazolam 2 mg provided moderate
prolongation of Postoperative analgesia without increasing motor block.
     Singapore Med J 2011 52(6)432-435
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Nanjegowda et al (36), in 2011 in a prospective, randomized double blind
study, investigated the intrathecalmidazolam on postoperative analgesic efficacy
and adverse effects in patients undergoing knee arthroscopy.50 ASA-I and
ASA-II patients of either sex aged between 18-56 years were allocated into two
groups. Group M received 2 ml of  0.5% Bupivacaine with 2 mg(0.4 ml)
preservative free midazolam and Group S received 2 ml of 0.5% heavy
Bupivacaine with 0.4 ml of 0.9% saline. Peak sensory level, total duration of
analgesia, duration of motor blockade, Pain score, and sedation score were
compared. Vital parameters like Heart rate, mean arterial blood pressure were
assessed.
 Pain score(i.e)VAS was lower in Group M than Group S and total duration
of analgesia was significantly high in group M and significantly prolonged
regression in group M. The peak sensory levels achieved in both groups were
comparable without any statistical difference.
VAS score was 33.6±4.6 and 56.6±8.64 in Group M and Group S
respectively. Duration of analgesia was 399.40±88.11 minutes and
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301.60±110.14 minutes in Group M and Group S respectively. Two segment
regression times was 120.12±7.26 minutes and 90.20±4.51 minutes in Group M
and Group S respectively.
 They concluded that intrathecal adjuvant preservative free midazolam    
2 mg to intrathecal 0.5% bupivacaine prolongs the duration of analgesia without
any adverse effects.
     South Afr J Anaesth Analg 2011 17(3) 255-259
Maryam shokrpur et al (4), conducted comparative study of intrathecal
midazolam and intrathecal  neostigmine with lidocaine in spinal anathesia in
women undergoing colporrhaphy.
 In this study sixty women were divided in to three groups. I group received
hyperparic lidocaine with on milligram of midazolam, II group received
hyperparic lidocaine with 50 mcg of neostigmine and III group received lidocaine
with normal saline. Pain score at 4 hrs, 12 hrs and 24 hrs were compared . The
duration of sensory block was prolonged in midazolam group . The VAS pain
score in midazolam group was lower than the other two groups.
JOURNAL OF FAMILY AND REPRODUCTIVE HEALTH VOL.6 , NO.2,
JUNE 2012
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Abdul muthalib hussain et al (5), conducted comparative study of
intrathecal ketamine and midazolam with bupivacaine for Postoperative
analgesia in lower limb and perianal surergeries. Among 80 patients, two groups
were divided. Group I received ketamine as adjuvant. Group II received
midazolam as adjuvant. In their study midazolam group had prolonged
Postoperative analgesia compared to ketamine group.
   BIO MEDICAL RESEARCH 2012; 23 (2); 259-267
Suchita A. Joshi et al (6) conducted study among 50 patients to assess
the comparative efficacy, safety and duration of analgesia produced by 30 mcg
clonidine and 2 mg midazolam with 15 mg hyperbaric 0.5% bupivacaine in lower
abdominal surgeries. In midazolam the onset of sensory block was 1.84 minutes
and duration of sensory block was 210.84 minutes where as in clonidine group
the onset of sensory and duration of block was 2.44 minutes and 169.28 minutes
respectively. The duration of postoperative analgesia was 391.64 minutes in
midazolam group but in clonidine group it was 296.60 minutes . The number of
analgesic doses was significantly less in midazolam group postoperatively in 24
hours. But in clonidine group 36% of patients had bradycardia and 44% of
patients had hypotension. None of the patients had bradycardia in midazolam
group and only 16% of the patient had hypo tension. In their study they
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administered first dose diclofenac 75 mg to all patients immediately after shifting
to ward. The average amount of diclofenac requirement was 153 mg in
midazolam group and 117 mg in clonidine group. They have concluded with
clonidine the postoperative analgesia is short lived with adverse effects.
Intrathecal midazolam provides superior analgesia without clinically relevant
side effects.
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MATERIALS AND METHODS
Study Design: Double blinded randomized case control study.
After obtaining approval from the institutional ethics committee, Thanjavur
Medical College, Thanjavur, the study was conducted in 60 ASA grade I or II
patients undergoing elective lower abdominal surgeries like Hernia repair and
appendicectomy under spinal anesthesia. Before including the patients for the
study, all patients were explained about the procedures and a written informed
consent was obtained.
INCLUSION CRITERIA
· Adult Patients aged 20-60 years of either sex
· ASA   I & II  Patients
· Weight:  35- 70 kg
· Height : 150-170 cm
EXCLUSION CRITERIA
· Infection at the site of injection
· Spinal deformity
· H/o Bleeding diathesis
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· H/o Chronic pain and on analgesics
· H/o Drug Allergy.
· H/o Psychiatric illness
PREOPERATIVE PREPARATION:
After routine preoperative assessment all patients were familiarized with
Visual Analog Scale (VAS). The patients were shown a 10 cm long scale marked
0-10 on a blank paper and told that 0 represented “no pain” and 10 represented
worst possible pain.
At the patient’s waiting room in the OT, basal line readings of the vital
parameters were recorded. Intravenous line started. Each patient received inj.
ranitidine 50 mg and inj. metoclopromide 10 mg before shifted to theatre.  The
patients were randomly allocated into two groups of 30 each by using closed
cover technique.
In the operating room, appropriate equipment for airway management and
emergency drugs were kept ready. The horizontal position of the operating table
was checked. Patients were shifted to the operating room and positioned.
Noninvasive blood pressure monitor, pulse oximeter and ECG leads were
connected to the patient. Preoperative baseline systolic and diastolic blood
pressure, mean arterial pressure, pulse rate, respiratory rate and oxygen
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saturation were recorded. Patients were preloaded with 10ml/ kg of ringer lactate
15min prior to the subarachnoid block. The Patient was placed in right lateral
position. The skin over the back was prepared with antiseptic solution and
draped with sterile towel.
BM GROUP
· Patients received 3ml 0.5% bupivacaine ( 15mg)
· 0.4 ml Midazolam (2 mg) preservative free
· 0.1 ml normal saline
BC GROUP
· Patients received 3 ml 0.5% bupivacaine ( 15mg)
· 0.2 ml clonidine ( 30 mg)
· 0.3 ml normal saline
The total volume of the injected solution was 3.5ml in both groups.
Lumbar puncture performed with a 25G Quincke’s spinal needle at L3 –
L4 inter space via midline approach. After confirming free flow of CSF, the
prepared solution was injected. The patients were made to lie supine immediately
after injection and the time at which the spinal anaesthesia performed was noted.
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The following parameters were recorded.
· Time of injection of subarachnoid Block.
· Time of onset of sensory block at T10 level.
· Maximum level of sensory block achieved ( by pinprick method)
· Time to achieve maximum level of sensory Block.
· Two segment regression time.
· Onset of Motor Block
· Duration of Complete motor recovery.
· Duration of Surgical procedure
· Sedation score
· Time to first dose of Postoperative analgesic
· Total dose of Postoperative analgesic
·  Systolic and diastolic blood pressure, mean arterial Blood
pressure pulse rate and oxygen saturation were recorded every 2
minutes for the first 10 minutes and thereafter every 5 minutes up
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to one hour.
· Hypotension is said to have occurred if the MAP falls less than
70mmHg and was treated with 100% 02, increasing the infusion
rate of IV fluids and inj. Ephedrine in incremental doses of 6 mg
at an interval of 2 minutes.
· Bradycardia was defined as heart rate less than 60/min and was
planned to be managed with intravenous atropine in incremental
doses.
· Respiratory depression was said to be present if respiratory rate
was less than 8 per minute and / or SpO2 <90%. It was planned
to be managed with mask ventilation or intubation and IPPV.
· Any discomfort like Nausea, Vomiting, Shivering, respiratory
depression and urinary retention are noted.
· Vomiting was planned to be managed with Inj. Odansetron 4 mg
intravenously.
· On completion of surgery Patients were shifted to post
anesthesia care unit for observation.  Patients were transferred to
postoperative ward after complete resolution of motor blockade
and stabilization of blood pressure. Vital signs were recorded
every 15 minutes in the first hour after surgery, 30 minutes for
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the next 2 hours and thereafter every hour for next 3 hours. Pain
assessment was done using VAS every 30 minutes till VAS
score of 4 was reached. The VAS was also noted whenever the
patient complained of pain.  Inj. Diclofenac sodium 75 mg was
given intramuscularly when VAS of 4 or more was reached.
Urinary retention was monitored postoperatively and
catheterization was planned in patients with retention more than
6 hours. Patients were monitored for 24 hours to detect side
effects like nausea, vomiting, dry mouth, Headache, Shivering,
respiratory depression.
SENSORY BLOCK
The onset of sensory block was defined as the time between the injection
of anaesthetic solution and the absence of pain at the T10 dermatome. Sensory
block was assessed by loss of sensation to pinprick using 21G Sterile needles
bilaterally along the midclavicular line. This assessment started immediately after
turning the patient to supine position and continued every minute till loss of
sensation to pinprick at T10 level was noted. This pinpricking continued till the
peak block height was reached and the time was noted. The duration of sensory
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block was defined as the time for regression of two segments from the maximum
block height evaluated by pin prick. Sensory block was checked every 15
minutes till it reached two segment regression levels.
MOTOR BLOCK
Motor Block was assessed bilaterally using Modified bromage scale.
MODIFIED BROMAGE SCALE
O - No block. Able to raise extended legs against gravity
1 - Unable to raise extended leg, but just able to flex knees.
2 - Unable to flex knees but able to flex ankle.
3 - Total block. Inability to flex ankle/ move leg.
Assessment of motor block was started immediately after turning the
patient to supine position and continued every minute till bromage score of 1 was
reached. The onset of motor block was defined as the time to achieve bromage
score of 1 from the time of injection. Duration for complete motor block recovery
was taken as the time from subarachnoid injection to return of bromage score of
0.
RAMSAY SEDATION SCORE
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Used to assess the degree of sedation.
1. Anxious and Agitated
2. Cooperative , oriented, tranquil
3. Responds only to verbal commands
4. Asleep with brisk response to light Stimulation
5. Asleep with Sluggish response to light stimulation
6. Asleep Without response to light stimulation
VISUAL ANALOG SCALE
  0-1 - Excellent  
  2-4 -  Good
  5-6 -  Fair
  7-8 -  Poor
  9-10 -  No relief
 When Pain score ≥4 –  supplementary analgesic was given.
DURATION OF ANALGESIA
The time at which the patient first complained of pain was noted. The
duration of effective analgesia was defined as the period from the spinal injection
to the first occasion when the patient complained of pain in the postoperative
period.
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OBSERVATION AND ANALYSIS
 We conducted a double blinded randomized control study in Thanjavur
medical college, Thanjavur to evaluate the effects of two adjuvants added to
intrathecal bupivacaine.
 The collected data were analyzed by chi square test and results obtained in
the form of range, mean and standard deviation. The probability value ‘P’ of less
than 0.05 considered statistically significant.
 Patient’s demographic data that includes age, sex and duration of surgery
between two groups were comparable.
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TABLE : 1
AGE DISTRIBUTION
Sl.no Variables
Sample group
BM Group BC Group Total
n = 30 100% n = 30 100% n = 60 100%
Age
Below 30yrs 12 40.0% 12 40.0% 24 40.0%
31 to 40yrs 7 23.3% 7 23.3% 14 23.3%
41 to 50yrs 5 16.7% 7 23.3% 12 20.0%
51yrs & above 6 20.0% 4 13.3% 10 16.7%
 The age distribution was in the range of 22-60 years in BM group
and 22-65 years in BC group. The ‘P’ value for mean age was not statistically
significant (‘P’ value = 0.866 > 0.05).
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FIGURE : 1
AGE DISTRIBUTION
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TABLE : 2
SEX DISTRIBUTION
Sl.no Variables
Sample group
BM Group BC Group Total
n = 30 100% n = 30 100% n = 60 100%
Sex
Male (BM) 25 83.3% 0 0% 25 41.7%
Female (BM) 5 16.7% 0 0% 5 8.3%
Male (BC) 0 0% 23 76.7% 23 38.3%
Female (BC) 0 0% 7 23.3% 7 11.7%
 Though male and female ratio are not equal in either group, statistics
between the groups for sex distribution was not significant (‘P’ value 0.752 >
0.05 by chi square test).
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  FIGURE :2
SEX DISTRIBUTION
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TABLE : 3
ONSET OF SENSORY AND MOTOR BLOCK
Onset of Sensory block at
T10 Mean ± S.D
Statistical
inference
BM Group (n=30) 2.17 ± 0.379
T=-14.253
0.000 < 0.05
Significant
BC Group (n=30) 3.90 ± 0.548
  The average time taken for onset of sensory block was 2.17 minutes
in BM group and 3.9 minutes in BC group. It was statistically significant (‘P’
value 0.000 < 0.05).
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TABLE : 4
Onset of Motor Block Mean ± S.D Statisticalinference
BM Group (n=30) 3.20 ± 0.407
T=-13.350
0.000 < 0.05
Significant
BC Group (n=30) 4.93 ± 0.583
  The onset of motor block was significantly faster in BM group
compared to BC group (3.2 minutes Vs 4.93 minutes ) which was statistically
significant ( ‘P’ value  0.000 < 0.05).
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FIGURE : 3
ONSET OF SENSORY AND MOTOR
BLOCK
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TABLE : 5
PEAK SENSORY LEVEL
Sl.no Peak sensory Level
Group sample
BM Group
(n=30)
BC Group
(n=30)
Statistical inference
1 T4 2 (6.7%) 3 (10%)
2 T6 24 (80%) 22 (73.3%)
3 T8 4 (13.3%) 5 (167%)
X2 = 0.398
Df = 2
0.820 > 0.05
Not Significant
 Level of the sensory block varied from T4 to T8 level among all
patients, 46 patients attained maximum level of sensory blockade at T6. Nine
patients attained up to T8 level. Five patients attained T4 level. It was
statistically not significant (‘P’ value 0.820 > 0.05).
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TABLE : 6
TIME TO ACHIEVE MAXIMUM SENSORY LEVEL
Time to achieve maximum sensory
level Mean ± S.D
Statistical
inference
BM Group (n=30) 7.37 ± 0.490
T=-17.171
0.000 < 0.05
Significant
BC Group (n=30) 10.17 ± 0.747
  The mean time to achieve maximum sensory level was 7.37 minutes
in BM group. But in BC group it was 10.17 minutes. The probability value as
detected by students‘t’ test is 0.000 < 0.05.
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FIGURE : 4
TIME TO ACHIEVE MAXIMUM SENSORY LEVEL
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TABLE : 7
TWO SEGMENT REGRESSION TIME AND DURATION OF
COMPLETE MOTOR RECOVERY
Two segment regression
time Mean ± S.D
Statistical
inference
BM Group (n=30) 211.67 ± 15.444
T=15.482
0.000 < 0.05
Significant
BC Group (n=30) 156.33 ± 12.030
Table : 7 / Figure : 5 show duration of two segment regression time in
minutes in BM group comparing to BC group (211.67 Vs 156.39 minutes) with
significant ‘P’ value (0.000 < 0.05).
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TABLE : 8
Duration of complete Motor
Recovery Mean ± S.D
Statistical
inference
BM Group (n=30) 292.00 ± 13.104
T=-8.904
0.000 < 0.05
Significant
BC Group (n=30) 319.00 ± 10.205
The table : 8 / figure : 5  shows prolonged duration of complete motor
recovery in BC group of 390 minutes with significant ‘P’ value (0.000 < 0.05).
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FIGURE : 5
COMPARISON OF TWO SEGMENT REGRESSION TIME AND
DURATION OF COMPLETE MOTOR RECOVERY
82
TABLE : 9
TIME TO FIRST POSTOPERATIVE ANALGSIA AND TOTAL DOSE
OF POSTOPERATIVE ANALGESIA
Time to first Postoperative
analgesia Mean ± S.D
Statistical
inference
BM Group (n=30) 486.17 ± 42.012
T=15.570
0.000 < 0.05
Significant
BC Group (n=30) 306.17 ± 47.374
  The mean duration of analgesia (time to first Postoperative analgesia) was
486.17 minutes with a range of 400 to 540 minutes in BM group. But in the BC
group it was 306.17 minutes with a range of 255-470 minutes. The probability
value, as detected by students‘t’ test was 0.000 < 0.05.
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FIGURE : 6
COMPARISON OF TIME TO FIRST POSTOPERATIVE ANALGSIA
AND TOTAL DOSE OF POSTOPERATIVE ANALGESIA
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TABLE : 10
Total dose of postoperative
analgesia
Mean ± S.D Statisticalinference
BM Group (n=30) 87.50 ± 28.429
T=-5.732
0.000 < 0.05
Significant
BC Group (n=30) 132.50 ± 32.264
   The mean value of total dose of Postoperative analgesia was very
less in BM group comparing to BC group (87.5 Vs 132.5 mg) which was
statistically significant ‘P’ value 0.000 < 0.05.
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TABLE  : 11
PULSE RATE
Time Interval
BM Group     
(Mean ± SD)
BC Group   (Mean
± SD) Statistical Inference
Base Line 86.40 ± 3.729 87.53 ± 2.726 0.184 > 0.05
2 minutes 81.87 ± 3.235 83.27 ± 3.600 0.119 > 0.05
4 minutes 79.63 ± 2.988 81.40 ± 3.359 0.036 < 0.05*
6 minutes 78.47 ± 3.148 79.67 ± 3.122 0.144 > 0.05
8 minutes 77.73 ± 2.59 78.37 ± 2.327 0.318 > 0.05
10 minutes 76.53 ± 2.270 77.33 ± 3.407 0.289 > 0.05
15 minutes 75.43 ± 2.788 75.63 ± 3.837 0.818 > 0.05
20 minutes 74.77 ± 2.775 73.50 ± 4.092 0.166 > 0.05
25 minutes 74.40 ± 3.147 71.57 ± 5.500 0.017 < 0.05*
30 minutes 74.63 ± 3.378 71.30 ± 5.408 0.006 < 0.05*
35 minutes 74.90 ± 3.241 71.73  ± 4.354 0.002 < 0.05*
40 minutes 74.30 ± 2.830 72.03 ± 4.214 0.018 < 0.05*
45 minutes 74.03 ± 3.368 72.5  ± 4.65 0.150 > 0.05
50 minutes 74.07 ± 3.084 72.77 ± 4.216 0.178 > 0.05
55 minutes 74.37 ± 3.479 73.87 ± 4.408 0.628 > 0.05
60 minutes 74.53 ± 3.550 74.00 ± 4.235 0.599 > 0.05
75 minutes 75.03 ± 3.168 74.97 ± 4.081 0.944 > 0.05
90 minutes 75.60 ± 3.480 75.60 ± 3.874 1.000 > 0.05
105 minutes 75.83 ± 3.733 75.53 ± 3.693 0.755 > 0.05
120 minutes 76.60 ± 3.747 76.67 ± 3.565 0.944 > 0.05
150 minutes 77.43 ± 3.607 77.00 ± 3.648 0.645 > 0.05
180 minutes 78.23 ± 3.664 77.37 ± 4.131 0.394 > 0.05
210 minutes 78.97 ± 3.882 77.77 ± 3.892 0.237 > 0.05
240 minutes 78.67 ± 3.845 78.53 ± 3.461 0.888 > 0.05
300 minutes 79.77 ± 3.181 78.50 ± 3.785 0.166 > 0.05
360 minutes 80.37 ± 3.232 79.00 ± 3.610 0.128 > 0.05
420 minutes 80.90 ± 3.209 79.53 ± 3.048 0.096 > 0.05
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FIGURE : 7
COMPARISON OF PULSE RATE
 We had monitored pulse rate from pre operative basal to 420th
minute. But only intra operative period has shown statistical significant
importance. Though there were reductions  in pulse rate between 2nd  and 10th
intervals  in BM group only at 4th  minute it was statistically significant
comparing to BC group (BM 79.63 ± 2.9 Vs BC 81.40 ± 3.3).
 Again there were reductions in pulse rate at 25th, 30th, 35th and
40th minute intervals in BC group comparing to BM group.
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TABLE : 12
MEAN ARTERIAL PRESSURE
Time Interval
BM Group
(Mean ± SD)
BC Group
(Mean ± SD)
Statistical
Inference
Base Line 93.43 ± 5.230 94.73 ± 5.112 0.334 > 0.05
2 minutes 90.27 ± 4.370 90.23 ± 3.980 0.975 > 0.05
4 minutes 87.13 ± 4.191 87.77 ± 4.158 0.559 > 0.05
6 minutes 86.03 ± 5.750 86.10 ± 4.358 0.960 > 0.05
8 minutes 83.93 ± 5.271 84.03 ± 4.552 0.938 > 0.05
10 minutes 82.87 ± 4.455 82.20 ± 4.021 0.545 > 0.05
15 minutes 82.33 ± 5.248 79.67 ± 4.978 0.048 <0 .05*
20 minutes 80.87 ± 5.770 78.10 ± 5.307 0.058 < 0.05*
25 minutes 79.2 7± 5.078 78.53 ± 5.438 0.591 > 0.05
30 minutes 79.10 ± 5.585 78.17 ± 4.292 0.471 > 0.05
35 minutes 79.03 ± 4.382 77.60 ± 4.651 0.224 > 0.05
40 minutes 79.27 ± 4.110 78.33 ± 3.73 0.361 > 0.05
45 minutes 79.60 ± 4.454 79.23 ± 4.150 0.743 > 0.05
50 minutes 78.83 ± 3.495 79.97 ± 4.214 0.262 > 0.05
55 minutes 78.57 ± 3.945 78.60 ± 4.005 0.974 > 0.05
60 minutes 79.50 ± 4.058 79.03 ± 3.952 0.653 > 0.05
75 minutes 80.10 ± 3.468 79.30 ± 4.380 0.436 > 0.05
90 minutes 80.47 ± 4.041 80.27 ± 4.127 0.850 > 0.05
105 minutes 80.80 ± 3.547 80.80 ± 3.881 1.000 > 0.05
120 minutes 81.37 ± 2.748 81.50 ± 4.855 0.896 > 0.05
150 minutes 82.03 ± 3.399 81.97 ± 4.279 0.947 > 0.05
180 minutes 82.83 ± 3.425 83.03 ± 4.367 0.844 > 0.05
210 minutes 82.90 ± 3.199 80.47 ± 14.788 0.382 > 0.05
240 minutes 84.40 ± 3.430 84.20 ± 4.131 0.839 > 0.05
300 minutes 85.07 ± 3.151 85.03 ± 3.378 0.969 > 0.05
360 minutes 86.83 ± 3.733 85.83 ± 3.797 0.308 > 0.05
420 minutes 87.10 ± 3.604 86.87 ± 3.461 0.799 > 0.05
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FIGURE : 8
COMPARISON OF MEAN ARTERIAL PRESSURE
  We had monitored mean arterial pressure from pre
operative basal to 420th minute. But only intra operative period has shown
statistically significant. There were reductions in mean arterial BP in 15th and
20th minute in BC group comparing to BM group and the corresponding ‘P’
value is 0.048 < 0.05 and 0.058 < 0.05 respectively.
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TABLE : 13
RESPIRATORY RATE
RR (/ minute) Mean ± S.D Statistical inference
BM Group (n=30) 13.97 ± 0.414
T=0.331
0.742 > 0.05
Not Significant
BC Group (n=30) 13.93 ± 0..365
 Respiratory rate was in the range of 13-15 per minute analyzed in both
groups and was not significant (‘P’ value 0.742 > 0.05).
TABLE : 14
O2 SATURATION
SPO2 Mean ± S.D Statisticalinference
BM Group (n=30) 98.27 ± 0.691
T=0.367
0.715 > 0.05
Not Significant
BC Group (n=30) 98.20 ± 0.714
Oxygen saturation was in the range of 97% -100%, analyzed in both
groups and was not significant (‘P’ value 0.715 > 0.05).
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TABLE : 15
SEDATION SCORE
SedationScore Mean ± S.D Statistical inference
BM Group (n=30) 2.83 ± 0.379
T=-0.750
0.456  > 0.05
Not Significant
BC Group (n=30) 2.90 ± 0.305
 Most of the patients had sedation score of 3 (the patients response only to
verbal comments) sedation score was not significant ‘P’ value 0.456 > 0.05.
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TABLE :16
ADVERSE EFFECTS
Sl.no Adverse effects
Group sample
BM Group
(n=30)
BC Group
(n=30)
Statistical inference
1 Bradycardia 0 6 (20%)
2 Hypotension 2 (6.7%) 7 (23.3%)
3 No Adverse effects 28 (93.3%) 17 (56.7%)
X2=11.467
Df=2
0.003 < 0.05
Significant
 The incidents of bradycardia and hypotension in group BM was
Significantly lower than that of group BC. Analysis was done using chi Square
test.  The ‘P’ value obtained was significant (0.003 < 0.05).
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FIGURE : 9
COMPARISON OF ADVERSE EFFECTS
93
DISCUSSION
The study was conducted to evaluate the effects of intrathecal midazolam
and clonidine as adjuvant to bupivacaine to assess hemodynamic stability and
postoperative analgesia in spinal anaesthesia.
Sixty patients were randomly selected and equally divided into two
groups. BM group received 3ml of 0.5% heavy bupivacaine, 0.4ml (2mg) of
midazolam (preservative free) and 0.1ml of normal saline. BC group received
3ml of 0.5% heavy bupivacaine, 0.2 ml (30 mcg) of Clonidine and 0.3ml of
normal saline.
Prakash et al (33), conducted a placebo controlled study to evaluate the
two different doses of intrathecal midazolam (1 mg and 2 mg) with 0.5%
bupivacaine (10 mg) and concluded that intrathecal midazolam 2 mg with
bupivacaine provided a moderate prolongation of postoperative analgesia and
reduced requirement of Postoperative analgesic supplements.
M.H Kim and Y.M Lee (30) evaluated 2 mg of intrathecal midazolam
with 5 mg of bupivacaine and proved prolonged Postoperative analgesia than 1
mg of intrathecal midazolam.
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Adam. P Tucker et al (31), has proved that the 2 mg of intrathecal
midazolam will not increase the incidence of neurological side effects. Hence in
our study we have chosen 2 mg intrathecal midazolam as adjuvant with
bupivacaine.
Hema Suxena et al (34), evaluated 3 different doses of clonidine (15, 30,
37.5 mcg) as adjuvant with bupivacaine (13.5 mg) in spinal anaesthesia. Even
with small doses of clonidine, there was significant improvement in onset and
duration of sensory and motor block with relative hemodynamic stability. They
have concluded 30 mcg dose provides maximum benefit and minimum side
effects. Hence we have selected 30 mcg of clonidine as adjuvant with
bupivacaine for comparative study. Suchita A. Joshi et al (6), conducted a study
to compare intrathecal midazolam and clonidine with 15 mg of 0.5% heavy
bupivacaine in lower abdomen surgeries.
 In our study the onset of sensory blockade was 2.17 minutes in BM group
and 3.9 minutes in BC group. But Suchita A. Joshi et al (6) in their study had
shorter onset of sensory blockade for the same volume of drug in both groups
comparing to our study. This is because they had L1 as the end point for onset of
sensory blockade instead of T10 in our study. This shows that intrathecal
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midazolam has significantly rapid onset of sensory blockade. Because midazolam
becomes highly fat soluble in body pH, it crosses the blood brain barrier more
easily to gain access to the receptors. This is consistent with the study conducted
by Shadangi B et al (35), AIIMS, New Delhi which concluded that intrathecal
midazolam has rapid onset of action than control group.
The onset of motor blockade was 3.2 minutes in BM group and 4.93
minutes in BC group. This shows that intrathecal midazolam has significantly
faster onset of motor block. But, In a study by Shadangi B et al (35), BM group
has shown a longer onset of motor blockade in BM group (6 minutes) which is
nearly twice that of BM group in our study (3.2 minutes) . This is due to the
difference in using modified bromage scale, we have taken 1 (unable to raise the
extended leg, but able to flex the knees) as the onset of motor blockade where as
Shadangi B et al (35), had taken 3 (Total block, inability to flex ankle / move
legs) as onset of motor blockade.
 In our study the level of sensory block varied from T4 to T8 level. Among
all patients, 46 patients attained maximum level of sensory blockade at T6 level.
Nine patients attained up to T8 level and five patients attained T4 level. Any
patient in either group does not complain of discomfort related to the sensory
levels. The results of Nanji Gowda et al (36) study, has shown that 2 mg
midazolam to intrathecal bupivacaine did not have any effect on peak level. 
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 In BM group the time to achieve maximum sensory level was 7.37 minutes
and in BC group was 10.17 minutes. This was statistically significant with the
study conducted by Suchita A. Joshi et al (6).
           In our study the duration of sensory block was 211.67 minutes in BM
group and 156.33 minutes in BC group. This is very similar to the findings of BM
groups (211.67±15.44 Vs 210.84±68.44) and BC groups (156.33±12.03 Vs
169.28±63.69) by Suchita A. Joshi et al (6). But comparing to BM group in our
study Shadangi B et al (35), had a lower duration of two segment regression
time (211.67 Vs 115.8 minutes). The reason for the difference it could be made
out was the volume of the drug. We have used 3.5 ml as the total volume similar
to Suchita A. Joshi et al (6), where as Shadangi B et al (35) used 3.4 ml in BM
group.
 In our study, in BM group the duration of complete motor recovery was
292 minutes whereas in BC group it was 319 minutes. This shows that the
duration of motor block was longer in clonidine group similar to Suchita A.
Joshi et al (6) study. Hema saxena et al (34) studied the efficacy of three
different doses of  intrathecal  clonidine with bupivacaine. In their study, group
III patients who received 30 mcg of clonidine had duration of motor blockade
220 ±47 minutes Vs 319±10.20 minutes in our study. The prolongation of motor
blockade in our study could be explained by the difference in drug concentration
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(13.5 mg Vs 15 mg) and also duration of motor blockade was longer in all
clonidine groups in dose dependant manner.
DURATION OF ANALGESIA
  In our study, the duration of analgesia (from the time of intrathecal
injection to the first dose of postoperative analgesia) was 486.17 minutes in BM
group and 306.17 minutes in BC group. This has shown that intrathecal
midazolam resulted in prolongation of duration of analgesia than intrathecal 
clonidine.
   The average dose of Postoperative analgesia in BM group was 87.5mg
whereas in BC group it was 132.5mg. This shows that intrathecal midazolam
significantly lowers the need for supplementary Postoperative analgesia than
intrathecal clonidine. So prolongation of duration of analgesia with significant
reduction in postoperative analgesic requirement confirms the antinociceptive
action of midazolam by its various mechanisms as shown by the C.S.Goodchild
et al. Study (29). First one is through GABA ‘A’ receptor mediated action,
second one through the endogenous release of opioids and third one is inhibition
of adenosine uptake. These finding were similar with Suchita A. Joshi et al       
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study (6).
Duration  of
Analgesia
(minutes)
BM Group BC Group
Sujitha et al
study Our Study Sujitha et al Our Study
391.64 486.17 296.60 306.17
M.H Kim and Y.M Lee et al (30) have shown that intrathecal midazolam
2mg with bupivacaine 5mg had prolonged duration of analgesia comparing to
midazolam 1mg with bupivacaine (8.37 hrs Vs 6.03 hrs).
In our study also BM group (2mg midazolam + Bupivacaine 0.5% 15mg
has the similar duration of analgesia (486.17 or 8.1 hrs).
Nidhi Agarwal et al (32) conducted study in lower abdominal surgeries
including endoscopic procedures with control and BM groups. BM group
received 15 mg of bupivacaine with 1mg midazolam. Their result shows that
duration of analgesia in BM group was 17.6 ± 8.87 hrs.
 The prolongation of duration of analgesia with intrathecal midazolam is
definitely longer than either control group (Kim Lee et al, and Nidhi Agarwal
et al) or clonidine group (Hema suxena et al and Suchita A. Joshi et al).
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Variation in the duration of analgesia in midazolam group of different studies
may be due to varied concentrations of bupivacaine, different doses of
midazolam and types of surgery.
Eisenach JC, Dekock M et al (24) found that analgesic effect of
clonidine was due to presynaptic alpha 2 agonist activities in substantia
gelatinosa in spinal cord.
  Hema Saxena et al  (34) have shown that the duration of analgesia in
patients who received 30mcg of clonidine with bupivacaine was 264 ± 43
minutes where as BC group in our study has 306.17 ± 47 minutes.
Postoperative analgesic requirements higher in both groups in Suchita A.
Joshi et al (6) study. It is due to administration of first dose of diclofenac 75 mg
to all patients immediately after shifting to the ward whereas we have
administrated the first dose of analgesic either at request or VAS score more than
4.
  We observed the duration of analgesia was prolonged in BM group than
BC group because of multimodal analgesic action of midazolam, mild sedation
mediated by alpha 1 GABAA receptor and anxiolysis mediated by alpha 2
GABAA receptor.
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HEMODYNAMIC STABILITY
             Various studies have demonstrated the hemodynamic stability when
midazolam and clonidine are added as adjuvants to intrathecal bupivacaine.
C.S.Goodchild and J Nobel et al (28) observed heart rate and blood pressure
remains unchanged till 30 minutes after intrathecal injection of midazolam. Nanji
Gowda et al (36) also observed similar results.
In our study there was a statistically significant reduction of pulse rate at
4th minute interval in BM group comparing to BC group which could be
explained by the earlier action of midazolam on α1 and α2 GABAA receptors
producing sedation and anxiolysis. There were statistically significant reductions
of pulse rate at 25th, 30th, 35th and 40th minutes in BC group comparing to BM
group. This could be explained by the presynaptic inhibition of norepinephrine
release and direct depression of AV node conduction after systemic absorption of
clonidine ().
                The mean arterial pressure was significantly lower in 15 minutes and
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20 minutes in BC group when compared with BM group. The reduction in mean
arterial pressure was due to inhibition of preganglionic sympathetic neurons in
spinal cord. Suchita A. Joshi et al (6) showed no statistical significant fall in
intraoperative blood pressure.
 In our study in BC group, six (20%) patients developed bradycardia while
none of the patients in BM group developed the same. Seven patients in BC
group (23.3%) developed hypotension whereas in BM group only two (6.7%)
patients. This shows that intrathecal clonidine had statistically significant adverse
effects comparing to BM group. Suchita et al (6) had similar result which
showed that the degree of bradycardia in  BM Vs BC was11% Vs 33% and the
degree of hypotension  in BM Vs BC was 21% Vs 28%.
 After administration of intrathecal midazolam, sympathetic nervous system
function remains intact (Goodchild et al (28)). Hence incidence of bradycardia
and hypotension were low in intrathecal midazolam. In our study also, intrathecal
midazolam has better hemodynamic stability when compared to intrathecal
clonidine.
 In our study in both groups no statistically significant changes was
observed in sedation score, respiratory rate and O2 saturation. This is consistent
with study conducted by Suchita A. Joshi et al (6).
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Adam P Tuker et al (31), evaluated 574 patients and observed for one
month and concluded administration of 2 mg of intrathecal midazolam did not
increase the neurological side effects. Shadangi et al (35), and Nanje Gowda et
al (36) found no significant adverse effects in patients who received intrathecal
midazolam.
SUMMARY
We conducted a double blinded randomized control study in 60 patients
belonging to ASA I and II undergoing elective lower abdominal surgeries in
Thanjavur Medical College. Patients of both sexes ranging between 22 to 65
years of age were included. Our aim was to evaluate the effects of intrathecal
midazolam 2mg and clonidine 30 mcg as adjuvant to bupivacaine for
hemodynamic stability and postoperative analgesia. Patients were divided
randomly using closed cover technique into two groups of 25 each.
Group BM received 3ml of 0.5% heavy bupivacaine, 0.4ml midazolam
(preservative free) and 0.1ml of normal saline. Group BC received 3ml of 0.5%
heavy bupivacaine, 0.2ml clonidine and 0.3 ml of normal saline. The total volume
of the injected solution was 3.5ml in both groups.
The onset of sensory and motor blockade, the duration of sensory and
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motor blockade, peak sensory level, time to achieve maximum sensory level,
changes in pulse rate, changes in mean arterial pressure, duration of analgesia,
postoperative analgesic requirements, respiratory rate, o2 saturation, sedation
score and adverse effects were noted in both groups.
The data collected were analyzed by Chi square test and students’t’ tests.
The results were obtained in the form of range, mean and standard deviation. The
probability value ‘P’ of less than 0.05 considered statistically significant.
We found that onset of sensory and motor blockade, time to achieve
maximum sensory level, and duration of complete motor recovery was earlier in
BM group than BC group. Duration of Sensory block and duration of analgesia
were prolonged in BM group than BC group.
In our study there was a statistical significant reduction of pulse rate at 4th
minute interval of BM group and 25th, 30th, 35th and 40th minutes in BC group.
The MAP was significantly lower in 15 minutes and 20 minutes in BC group
when compared with BM group.
In both groups, no significant changes were observed in respiratory rate,
O2 saturation and sedation in our study. Postoperative analgesic requirements
and adverse effects were lower in BM group than BC group.
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CONCLUSION
  Intrathecal Midazolam as an adjuvant to bupivacaine comparing to
Clonidine resulted
1. Rapid onset of sensory and motor blockade,
2. Achieves maximum sensory level at a shorter interval
3. Increased duration of sensory blockade and decreased duration of
Motor blockade
4. Prolonged duration of analgesia and reduced requirement of post
operative analgesics.
5. It gives stable mean arterial pressure and pulse rate.
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PROFORMA
A STUDY TO COMPARE THE EFFECT OF MIDAZOLAM AND CLONIDINE
ADDED AS AN ADJUVANT TO INTRATHECAL BUPIVACAINE IN LOWER
ABDOMINAL SURGERIES
NAME     HT  DIAGNOSIS
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PREANAESTHETIC EVALUATION :
HISTORY  :
PR       CVS   
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TIME PR BP (SBP/DBP/MAP) RR SPO2 ADVERSE EFFCTS
LIST OF ABBREVIATIONS
1. CSF  : CEREBRO SPINAL FLUID
2. NMDA : N-METHYL D-ASPARTATE
3. MW : MOLECULAR WEIGHT
4. GABA : GAMMA AMINO BUTYRIC ACID
5. ECG : ELECTRO CARDIO GRAM
6. EEG : ELECTRO ENCEPHALO GRAM
7. ASA : AMERICAN SOCIETY OF ANAESTHESIOLOGIST
8.VAS  : VISUAL ANALOG SCALE
9.MAP : MEAN ARTERIAL PRESSURE
10.IPPV : INTERMITENTPOSITIVEPRESSUREVENTILATION
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2 88 84 84 80 76 74 75 77 76 75 73 70 72 73 75 74 75 76 74 77 79 77 80 82 84 85 82
3 92 86 84 80 78 76 72 73 68 68 70 71 73 75 74 73 77 76 74 75 77 79 80 82 80 81 80
4 90 91 90 88 84 85 80 78 76 77 75 74 76 77 76 75 76 75 79 80 79 82 80 81 83 80 82
5 84 82 80 80 79 80 78 79 76 73 75 74 77 74 75 76 77 79 78 80 79 80 78 80 82 81 80
6 86 80 79 76 74 73 71 70 68 70 67 69 70 71 74 75 77 78 79 75 76 75 77 75 76 77 79
7 89 84 80 80 78 79 74 73 72 71 73 71 73 72 70 72 76 75 75 74 73 72 76 77 74 78 79
8 92 86 80 78 79 80 78 72 70 64 67 66 68 69 70 71 69 70 71 73 71 72 71 74 75 74 76
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13 94 92 90 86 82 80 78 72 71 73 72 75 72 75 77 76 79 80 80 82 81 80 81 83 82 80 82
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17 87 82 80 80 82 84 84 82 84 82 80 80 79 82 82 82 78 80 80 81 83 85 82 80 78 78 78
18 84 80 76 76 74 76 70 70 72 70 68 64 60 76 80 78 78 78 76 78 76 78 80 82 82 80 80
19 84 80 80 81 79 79 78 79 76 75 73 72 68 64 64 63 69 70 71 72 74 73 77 76 75 77 79
20 90 90 86 84 82 78 77 76 77 75 77 78 74 75 72 74 75 76 77 75 76 77 75 77 79 80 80
21 86 82 80 82 80 78 79 77 75 74 73 75 76 74 75 77 78 76 74 73 77 79 78 80 81 80 81
22 86 82 80 79 79 77 75 70 60 74 73 75 77 78 78 79 77 76 77 79 78 77 80 79 82 81 80
23 90 87 88 82 79 79 77 75 64 60 65 72 74 77 79 77 80 80 78 79 77 78 80 80 79 80 81
24 90 84 84 81 78 79 79 77 77 78 79 79 80 81 82 82 80 78 82 80 80 82 81 79 80 82 84
25 86 80 78 79 77 77 77 75 74 71 70 69 68 66 69 68 69 70 71 73 71 73 72 74 73 77 74
26 88 87 82 80 79 79 72 64 60 70 74 73 75 72 76 77 77 79 80 79 80 79 81 80 79 80 80
27 86 82 80 80 78 78 78 76 76 76 74 72 70 70 72 68 68 69 70 72 72 74 72 72 70 70 76
28 88 82 80 80 78 74 72 70 68 66 62 64 65 67 69 70 75 73 74 75 77 74 75 77 76 77 80
29 88 82 80 80 78 79 76 75 77 78 77 75 74 73 77 76 73 77 77 79 80 78 79 79 80 81 82
30 88 86 80 76 77 68 64 65 62 60 69 74 78 75 77 79 82 83 78 84 85 87 86 85 82 84 83
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26 90 82 80 76 75 73 72 72 75 74 73 75 74 76 73 77 74 75 76 74 77 79 80 81 82 84 80
27 88 80 78 76 75 76 74 73 74 76 75 77 76 77 75 76 77 79 76 80 80 81 80 80 81 80 83
28 86 80 78 79 80 74 75 77 73 74 75 76 75 74 77 75 75 76 74 78 74 77 76 74 73 75 80
29 88 84 80 80 80 78 78 79 80 78 76 76 77 74 76 77 78 70 70 72 72 72 74 74 76 76 78
30 90 86 84 82 80 80 76 77 72 75 77 76 75 72 74 73 76 77 78 79 81 79 80 81 80 81 82
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3 99 93 90 93 90 87 88 88 83 81 80 79 82 84 80 79 82 84 81 82 81 83 81 83 84 88 86
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3 89 92 86 84 81 83 85 80 81 80 80 78 77 79 78 77 79 77 80 81 83 85 81 80 82 84 84
4 102 95 92 89 93 93 89 95 89 90 88 88 88 80 78 83 83 88 87 84 81 84 81 85 89 93 89
5 93 89 91 93 86 84 88 87 84 83 82 83 84 82 83 80 80 80 84 82 83 83 82 85 82 83 83
6 94 91 89 93 88 84 85 83 83 83 82 79 79 75 72 73 80 78 77 79 78 77 79 81 82 85 84
7 95 92 87 88 88 88 84 82 79 81 80 82 83 80 81 80 82 83 80 83 82 80 81 85 84 88 87
8 100 95 85 82 81 79 77 75 73 69 76 80 80 79 76 76 80 80 79 78 79 87 82 81 83 88 84
9 101 97 91 95 88 88 90 88 87 83 83 83 87 81 82 83 79 86 86 82 83 84 87 90 90 95 98
10 92 94 95 95 92 89 93 93 86 88 91 89 87 83 88 91 89 87 83 81 85 82 87 90 88 94 91
11 104 102 100 98 94 88 91 90 87 89 82 84 89 88 82 78 84 85 85 82 81 84 85 83 84 89 91
12 89 87 84 83 82 85 83 80 80 80 78 79 77 80 79 83 82 83 83 84 85 85 83 87 84 84 86
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14 92 90 86 82 81 79 77 76 75 73 72 74 76 75 77 79 81 83 84 84 85 87 88 88 89 85 87
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1 48 M 13 99 4 5 T6 10 155 315 75 300 150 3 Nil
2 41 M 14 98 5 6 T6 10 145 310 90 285 150 3 Nil
3 30 M 14 99 4 5 T6 9 150 335 75 255 150 3 Nil
4 32 M 14 98 4 5 T8 11 160 300 75 285 150 3 Nil
5 50 M 14 97 3 4 T6 11 160 310 75 270 150 3 Nil
6 22 M 14 99 3 4 T6 11 160 310 75 300 75 3 Hypotension
7 29 F 14 98 4 5 T4 11 205 325 90 420 75 3 Hypotension
8 31 M 15 99 4 5 T6 11 155 300 75 300 150 3 Nil
9 33 M 14 98 4 5 T6 11 145 325 90 270 150 3 Nil
10 45 M 14 97 5 6 T6 10 165 315 75 315 150 3 Nil
11 28 M 14 98 3 4 T6 10 165 320 75 470 75 3 Hypotension
12 30 M 14 100 4 5 T6 11 160 300 90 300 150 3 Nil
13 31 F 14 98 4 5 T6 10 160 325 75 270 150 3 Nil
14 58 M 14 98 3 4 T4 11 160 320 75 290 150 3 Bradycardia
15 60 M 13 98 4 5 T8 10 150 300 75 300 150 3 Nil
16 27 M 14 98 3 4 T4 10 150 310 75 300 75 3 Hypotension
17 34 M 14 99 4 5 T6 9 165 315 80 300 150 2 Nil
18 28 M 14 99 4 6 T6 10 165 330 75 300 150 3 Bradycardia
19 18 F 13 98 4 5 T6 10 145 330 75 300 150 3 Nil
20 20 M 14 98 4 5 T6 9 145 330 75 360 75 3 Hypotension
21 45 F 14 98 4 5 T8 10 140 325 90 270 150 3 Nil
22 29 M 14 97 4 5 T6 10 150 325 75 285 150 2 Bradycardia
23 34 F 14 98 3 4 T8 10 165 325 75 285 150 3 Bradycardia
24 54 M 14 98 4 5 T6 10 150 315 75 310 150 3 Nil
25 25 F 14 99 4 5 T6 9 150 330 75 285 150 3 Nil
26 65 M 14 98 4 5 T8 11 160 325 90 285 150 2 Bradycardia
27 45 M 14 98 4 5 T6 9 160 325 75 270 75 3 Hypotension
28 36 M 14 97 4 5 T6 11 160 325 75 405 75 3 Hypotension
29 42 F 14 98 4 5 T6 9 140 330 80 300 150 3 Nil
30 28 M 14 99 5 6 T6 11 150 320 75 300 150 3 Bradycardia
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1 49 M 14 98 2 3 T6 7 200 300 70 400 75 3 Nil
2 35 M 13 99 2 3 T6 7 190 290 75 450 75 2 Nil
3 50 M 13 97 2 3 T6 8 210 290 90 480 75 3 Nil
4 58 M 14 99 2 3 T6 8 195 285 75 480 75 2 Nil
5 44 M 14 99 3 4 T8 8 200 315 80 420 75 3 Nil
6 38 M 14 99 2 3 T6 7 200 305 75 420 150 3 Nil
7 34 M 14 98 3 4 T6 8 210 315 75 465 75 3 Nil
8 55 M 15 98 2 3 T4 7 225 285 80 420 75 3 Hypotension
9 32 M 14 99 3 4 T6 7 210 325 80 435 75 3 Nil
10 30 M 14 98 3 4 T6 8 180 300 80 450 75 2 Nil
11 55 M 15 99 2 4 T6 7 200 300 75 520 75 2 Nil
12 26 M 14 99 2 3 T6 7 205 310 75 480 150 3 Nil
13 60 M 13 97 2 3 T6 7 215 285 75 540 75 3 Nil
14 52 M 14 98 2 3 T8 8 225 285 75 510 150 3 Nil
15 40 M 14 98 2 3 T6 7 200 285 90 525 75 3 Nil
16 60 M 14 98 2 3 T6 7 215 285 75 525 75 3 Nil
17 41 M 14 99 2 3 T8 7 230 285 90 525 150 3 Nil
18 22 M 14 98 2 3 T4 7 240 270 75 465 75 3 Hypotension
19 22 F 14 98 2 3 T6 8 210 290 75 525 75 3 Nil
20 30 F 14 98 2 3 T6 7 250 280 80 510 75 3 Nil
21 25 F 14 99 2 3 T6 8 210 300 75 480 75 2 Nil
22 28 M 14 97 2 3 T6 8 240 300 75 480 75 3 Nil
23 22 F 14 98 2 3 T6 7 210 285 75 450 75 3 Nil
24 22 F 14 99 3 4 T6 7 220 270 75 480 75 3 Nil
25 25 M 14 98 2 3 T6 8 220 290 75 540 75 3 Nil
26 40 M 14 98 2 3 T6 8 210 290 75 540 75 3 Nil
27 28 M 14 97 2 3 T6 7 195 280 90 540 75 3 Nil
28 45 M 14 99 2 3 T8 7 215 280 75 540 150 3 Nil
29 20 M 14 99 2 3 T6 7 200 300 80 495 75 3 Nil
30 38 M 14 98 2 3 T6 7 220 280 75 495 75 3 Nil
